These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17517623)

  • 21. Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation.
    Benussi L; Ghidoni R; Paterlini A; Nicosia F; Alberici AC; Signorini S; Barbiero L; Binetti G
    Exp Cell Res; 2005 Aug; 308(1):78-84. PubMed ID: 15904919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?
    Luo W; Rodina A; Chiosis G
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S7. PubMed ID: 19090995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau and tauopathies.
    Lee G; Leugers CJ
    Prog Mol Biol Transl Sci; 2012; 107():263-93. PubMed ID: 22482453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of glob1 suppresses pathogenesis of human neuronal tauopathies in Drosophila by regulating tau phosphorylation and ROS generation.
    Nisha ; Sarkar S
    Neurochem Int; 2021 Jun; 146():105040. PubMed ID: 33865914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement.
    Fontaine SN; Rauch JN; Nordhues BA; Assimon VA; Stothert AR; Jinwal UK; Sabbagh JJ; Chang L; Stevens SM; Zuiderweg ER; Gestwicki JE; Dickey CA
    J Biol Chem; 2015 May; 290(21):13115-27. PubMed ID: 25864199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.
    Blair LJ; Nordhues BA; Hill SE; Scaglione KM; O'Leary JC; Fontaine SN; Breydo L; Zhang B; Li P; Wang L; Cotman C; Paulson HL; Muschol M; Uversky VN; Klengel T; Binder EB; Kayed R; Golde TE; Berchtold N; Dickey CA
    J Clin Invest; 2013 Oct; 123(10):4158-69. PubMed ID: 23999428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.
    Yu A; Fox SG; Cavallini A; Kerridge C; O'Neill MJ; Wolak J; Bose S; Morimoto RI
    J Biol Chem; 2019 May; 294(19):7917-7930. PubMed ID: 30936201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
    Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
    Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An acetylation site in the middle domain of Hsp90 regulates chaperone function.
    Scroggins BT; Robzyk K; Wang D; Marcu MG; Tsutsumi S; Beebe K; Cotter RJ; Felts S; Toft D; Karnitz L; Rosen N; Neckers L
    Mol Cell; 2007 Jan; 25(1):151-9. PubMed ID: 17218278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
    Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
    Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau triage decisions mediated by the chaperone network.
    Cook C; Petrucelli L
    J Alzheimers Dis; 2013; 33 Suppl 1():S145-51. PubMed ID: 22596270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau in physiology and pathology.
    Wang Y; Mandelkow E
    Nat Rev Neurosci; 2016 Jan; 17(1):5-21. PubMed ID: 26631930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases.
    Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A
    Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
    Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
    J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting heat shock proteins in tauopathies.
    Deture M; Hicks C; Petrucelli L
    Curr Alzheimer Res; 2010 Dec; 7(8):677-84. PubMed ID: 20678072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tau phosphorylation: physiological and pathological consequences.
    Stoothoff WH; Johnson GV
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):280-97. PubMed ID: 15615646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
    Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
    J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylated tau and the neurodegenerative foldopathies.
    Kosik KS; Shimura H
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):298-310. PubMed ID: 15615647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.
    Xu W; Yuan X; Beebe K; Xiang Z; Neckers L
    Mol Cell Biol; 2007 Jan; 27(1):220-8. PubMed ID: 17030621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.